Concepedia

J Sigmund

JS

14

Publications

687

Citations

13

H-Index

1979

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

Discovery Institute

J Sigmund is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and biochemistry.

Top concepts

Publications per year

1979–2017

14

Publications

14

Discovery of FabH/FabF Inhibitors from Natural Products

Katherine Young, Hiranthi Jayasuriya, John G. Ondeyka et al. · Antimicrobial Agents and Chemotherapy · 2006 · 199 citations · Full text

, , +19

Discovery of Kibdelomycin, A Potent New Class of Bacterial Type II Topoisomerase Inhibitor by Chemical-Genetic Profiling in Staphylococcus aureus

John W. Phillips, Michael Goetz, Scott K. Smith et al. · Chemistry & Biology · 2011 · 163 citations

, , +10

Quinoxapeptins: Novel Chromodepsipeptide Inhibitors of HIV-1 and HIV-2 Reverse Transcriptase. I. The Producing Organism and Biological Activity.

Russell B. Lingham, Amy Hsu, JULIE A. O' BRIEN et al. · The Journal of Antibiotics · 1996 · 52 citations

Satellite association frequency and number of nucleoli depend on cell cycle duration and NOR-activity

J Sigmund, H. G. Schwarzacher, Aavo‐Valdur Mikelsaar · Human Genetics · 1979 · 49 citations

, , +8

Cochinmicins, novel and potent cyclodepsipeptide endothelin antagonists from a Microbispora sp. I. Production, isolation, and characterization.

Y. K. TONY LAM, David L. Williams, J Sigmund et al. · The Journal of Antibiotics · 1992 · 41 citations · Full text

Rows per page

1–5 of 14